On Friday, Theriva Biologics Inc (AMEX: TOVX) was 4.86% up from the session before settling in for the closing price of $0.26. A 52-week range for TOVX has been $0.20 – $2.08.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 39.99%. When this article was written, the company’s average yearly earnings per share was at 80.61%. With a float of $32.97 million, this company’s outstanding shares have now reached $33.74 million.
Theriva Biologics Inc (TOVX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Theriva Biologics Inc stocks. The insider ownership of Theriva Biologics Inc is 2.27%, while institutional ownership is 1.30%.
Theriva Biologics Inc (TOVX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -11.49 earnings per share (EPS) during the time that was less than consensus figure (set at -7.22) by -4.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.81% during the next five years compared to 39.99% growth over the previous five years of trading.
Theriva Biologics Inc (AMEX: TOVX) Trading Performance Indicators
You can see what Theriva Biologics Inc (TOVX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.90. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.54, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.28 in one year’s time.
Technical Analysis of Theriva Biologics Inc (TOVX)
Compared to the last year’s volume of 4.68 million, its volume of 1.85 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 78.97%.
During the past 100 days, Theriva Biologics Inc’s (TOVX) raw stochastic average was set at 10.40%, which indicates a significant decrease from 67.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0262 in the past 14 days, which was lower than the 0.0435 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3511, while its 200-day Moving Average is $0.6768. Nevertheless, the first resistance level for the watch stands at $0.2755 in the near term. At $0.2812, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.2892. If the price goes on to break the first support level at $0.2618, it is likely to go to the next support level at $0.2538. Should the price break the second support level, the third support level stands at $0.2481.
Theriva Biologics Inc (AMEX: TOVX) Key Stats
There are 33,740K outstanding shares of the company, which has a market capitalization of 9.11 million. As of now, sales total 0 K while income totals -25,650 K. Its latest quarter income was 0 K while its last quarter net income were -4,360 K.
